These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Pearls & Oy-sters: Iatrogenic relative hypotension leading to diffuse internal borderzone infarctions and coma. Kurowski D; Mullen MT; Messé SR Neurology; 2016 Jun; 86(24):e245-7. PubMed ID: 27298453 [No Abstract] [Full Text] [Related]
47. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan. Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786 [No Abstract] [Full Text] [Related]
48. Prolonged hypotension and ultrastructural changes in sympathetic neurones following guanacline treatment. Burnstock G; Doyle AE; Gannon BJ; Gerkens JF; Iwayama T; Mashford ML Eur J Pharmacol; 1971 Jan; 13(2):175-87. PubMed ID: 5544070 [No Abstract] [Full Text] [Related]
49. Clinical experience with guanfacine in long-term treatment of hypertension. Jerie P Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):37S-47S. PubMed ID: 6994777 [No Abstract] [Full Text] [Related]
50. Captopril in a hyponatraemic hypertensive: need for caution in initiating therapy. Atkinson AB; Brown JJ; Morton JJ; Leckie B; Fraser R; Lever AF; Robertson JI Lancet; 1979 Mar; 1(8115):557-8. PubMed ID: 85145 [No Abstract] [Full Text] [Related]
51. Prazosin: severe side effects are dose-dependent. Rosendorff C Br Med J; 1976 Aug; 2(6034):508. PubMed ID: 953651 [No Abstract] [Full Text] [Related]
52. Older people remain on blood pressure agents despite being hypotensive resulting in increased mortality and hospital admission. Morrissey Y; Bedford M; Irving J; Farmer CK Age Ageing; 2016 Nov; 45(6):783-788. PubMed ID: 27496937 [TBL] [Abstract][Full Text] [Related]
53. Potential improvements in antihypertensive drug treatment. Birkenhäger WH; de Leeuw PW Neth J Med; 1990 Aug; 37(1-2):49-52. PubMed ID: 2145520 [No Abstract] [Full Text] [Related]
54. [An increase in cardiovascular mortality caused by antihypertensive drugs. The need for a gradual and sustained effect]. Velasco J; Fernández Vidal P Rev Clin Esp; 1989 Oct; 185(6):39. PubMed ID: 2623245 [No Abstract] [Full Text] [Related]
55. Prazosin in the treatment of hypertension. Adriaensen H; Vryens R Practitioner; 1975 Feb; 214(1280):268-73. PubMed ID: 1096120 [TBL] [Abstract][Full Text] [Related]
56. Experience with prazosin in the treatment of hypertension. Bolli P; Simpson FO Postgrad Med; 1975 Nov; Spec No():69-76. PubMed ID: 1105487 [TBL] [Abstract][Full Text] [Related]
57. [Potentiation of the antihypertensive effect of captopril by diuretics (author's transl)]. Waeber B; Brunner HR; Turini GA; Curtet N; Keller I; Gavras H Ann Cardiol Angeiol (Paris); 1979; 28(1):9-11. PubMed ID: 219758 [No Abstract] [Full Text] [Related]
58. Effects of guancydine on systemic and renal hemodynamics in arterial hypertension. Villarreal H; Arcila H; Ramirez MA Clin Pharmacol Ther; 1971; 12(5):838-42. PubMed ID: 4936149 [No Abstract] [Full Text] [Related]
59. [Results of a controlled clinical study on a new retard antihypotensive agent with reference to Schellong's test]. Hunold W Z Allgemeinmed; 1975 Mar; 51(8):383-5. PubMed ID: 1094756 [No Abstract] [Full Text] [Related]
60. Clinical trial with guanabenz, a new antihypertensive agent. Nash DT J Clin Pharmacol; 1973 Oct; 13(10):416-21. PubMed ID: 4583572 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]